Khalid Youssif to Asharq Al-Awsat: Collapse of Sudanese State Possible if War Persists

Khalid Omer Youssif (AFP)
Khalid Omer Youssif (AFP)
TT

Khalid Youssif to Asharq Al-Awsat: Collapse of Sudanese State Possible if War Persists

Khalid Omer Youssif (AFP)
Khalid Omer Youssif (AFP)

Khalid Omer Youssif, one of Sudan’s notable opposition figures and former minister, characterized the ongoing conflict in the North African country as a futile “war with no victors.” He highlighted the nation as the ultimate loser in this conflict and cautioned of the potential “dismantlement of the state” if the war persists.

Speaking to Asharq Al-Awsat in an online interview, Youssif emphasized the urgent need for halting the conflict “immediately.”

Youssif, also a spokesman of Sudan’s political process, denounced claims that the country’s Forces of Freedom and Change (FFC) and civil signatories of the “Framework Agreement” were contributing to the conflict.

He rejected allegations directed at the FFC and civilian parties, labeling them as “falsehoods” propagated by members of the National Congress Party (NCP), established by Sudan's deposed leader, Omar al-Bashir, to conceal their involvement in initiating and perpetuating the conflict.

Youssif emphasized that the FFC was alert to the former regime’s efforts to create division between the Sudanese Armed Forces and the Rapid Support Forces (RSF) and presented a political and negotiation-based solution to avoid armed conflict.

He added that the alliance had established a political agreement with the leadership of the army, RSF, and civilian forces to reform the security and military sectors. Youssif asserted that the FFC had pursued this objective, even up to the day before the outbreak of the fighting.

Youssif revealed that there is continued communication between the signatories of the Framework Agreement and the leadership of the army and the RSF.

The Sudanese spokesman stated that the “US-Saudi initiative has made significant progress in extending the ongoing humanitarian ceasefire and organizing a direct meeting to achieve a permanent end to hostilities, which will pave the way for a comprehensive political solution.”

He further mentioned that the FFC wholeheartedly supports this initiative as a genuine opportunity to bring an end to the war.

Youssif voiced his optimism for “a close end to the wretched war,” but also cautioned about “the collapse of the country.”

“We aspire and strive for an immediate end to the conflict, hopefully by today or tomorrow,” he said.

“This wretched war will ultimately lead to the country's downfall and ruin,” he warned.

“Our hope lies in the widespread popular rejection of the war and the realization that it is a losing battle for the nation, with no good outcome to be expected from it whatsoever,” explained Youssif.

According to Youssif, stopping the war is the “utmost priority” and should come before considering any other political options.

He also expressed confidence that the conflict has not shattered the Sudanese people’s aspirations for a democratic and civilian government.



Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation
TT

Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation

Dr. Mehmood Khan, CEO of the Hevolution Foundation, the largest philanthropy organization funding aging medicine in the world, expressed that receiving Saudi citizenship will boost his scientific and practical capabilities.
He said this new status will help him advance his research, especially in addressing aging.
This comes as part of a recent royal decree granting Saudi citizenship to several notable scholars, doctors, researchers, and innovators.
“Our Chairman, his Royal Highness (Crown Prince Mohammed bin Salman), has very high expectations of our work and the impact we need to do; We were created in part because of his vision,” Khan told Asharq Al-Awsat.
“Living up to the expectations and challenges we get faced with is itself exciting, but it is challenging,” revealed Khan, affirming that Hevolution’s team is “up to that task.”
Khan, who has experience in both corporate and medical fields, told Asharq Al-Awsat that his work across academic, public, and private sectors has been a continuous learning process, with each area enhancing the others.
According to the CEO, these industries are interconnected, and combining their strengths often leads to the best solutions.
This insight inspired the Hevolution initiative, which brings together the scientific community, NGOs, pharmaceutical companies, policymakers, academia, biotech firms, CEOs, and others to promote healthy aging.
Khan highlighted the value of integrating insights from different sectors.
Academia provides detailed research, the public sector offers insights on population health and regulations, and the corporate world brings innovation and efficiency, explained Khan, adding that by merging these perspectives, the world can tackle complex health challenges more effectively.
“We’ve been working through, and are now investing, funding and partnering with over 200 scientists around the world, and over 150 different university labs,” said Khan.
Hevolution uses this integrated approach to advance healthy aging.
This initiative embodies my passion for addressing major challenges and offers a significant opportunity to make a global impact.
Khan talked about the first $400 million commitment Hevolution made in the last 23 months, calling it “unprecedented.”
“There has never been a non-profit organization in the world that has gone from not existing to now becoming the largest philanthropy funding aging biology and medicine in the world,” affirmed Khan.
Khan stressed that work at Hevolution not only pushes scientific boundaries but also promotes cross-sector collaboration to improve global health outcomes.
Since Khan’s early days in medical school, he’s been deeply interested in nutrition and population health, which was an unconventional focus back then. This journey set the foundation for his later work in community health.
Khan’s time as an endocrinology faculty member at the Mayo Clinic was crucial. He led programs on diabetes, endocrine diseases, metabolism, and nutrition, which strengthened his expertise in designing disease prevention systems.
In the private sector, Khan took on a key role at Takeda Pharmaceutical as the global head of R&D, which shaped his approach to innovative healthcare solutions.
At PepsiCo, as Chief Scientific Officer, he learned crucial principles of scale, impact, transformation, and tackling global challenges.
As CEO of Hevolution, Khan uses all his professional experience to advance the foundation’s mission of developing health sciences to address age-related diseases.
Khan serves on the boards of Reckitt Benckiser and the Saudi Research, Development, and Innovation Authority (RDIA).
He is the CEO of Life Biosciences, a member of Saudi Arabia’s biotechnology strategy committee, and the chair of the advanced technology visiting committee at the US National Institute of Standards and Technology (NIST).
Khan told Asharq Al-Awsat that he feels honored to have recently become a Saudi citizen by royal decree, while also holding dual US and UK citizenship. This helps him lead Hevolution effectively and work closely with international partners.
Khan commented on his recent Saudi citizenship, saying that in addition to feeling honored to receive Saudi citizenship by royal decree, alongside other distinguished individuals, this recognition is a great privilege.
Being a Saudi citizen, as per Khan, is a significant milestone and acknowledges the progress in his work in aging science and global health. It also strengthens Khan’s commitment to the work at Hevolution.
Khan noted that this new status enhances his ability to build relationships and collaborate within the Kingdom and internationally. It offers a deeper connection with the local community and better opportunities to engage with policymakers and leaders.
He also said that this recognition boosts Hevolution’s global presence and credibility, making the foundation’s collaborations with international scientists and business leaders stronger. It positions Hevolution as a key player in addressing age-related diseases.
Khan emphasized that this honor reflects the hard work and innovation of Hevolution’s entire team.
The CEO said that it was collective efforts that have made this achievement possible.
Khan also said he is excited to engage more deeply with the scientific and medical community in the Kingdom, adding that his new citizenship helps him contribute to Vision 2030 and the national biotechnology strategy, promoting innovation and attracting top global talent.